A review of complaints to the Consumer Financial Protection Bureau’s (CFPB) Consumer Complaint Database reveals a sharp spike in consumer complaints about auto purchasing, leasing and finance since the beginning of the pandemic.
In light of the COVID-19 pandemic, now more than ever, we need to work together to ensure that our government has a coordinated, strategic response to safeguard the public’s health, protect consumers from emerging dangers and ensure people can still participate fully in our democracy.
Top health experts from Oregon and across the country called on Gov. Kate Brown to shut the state down in response to recent surges in COVID-19 cases. Building on OSPIRG’s work to track critical public health metrics around the containment of COVID-19 in Oregon, the letter also recommends that Oregon significantly ramp up its testing and contact tracing capacity.
A U.S. PIRG Education Fund analysis has found that since March 2020, public consumer complaints at the federal Consumer Financial Protection Bureau have skyrocketed, setting a new monthly record each month. During this period, one in five complaints concerning mortgages, student loans or vehicle financing has mentioned the coronavirus crisis.
We can't do it without you.
OSPIRG is your advocate for the public interest, speaking out for healthier, safer, more secure lives for all of us.
News & Research
What to do before you go to vote, what to take with you and how to stay safe while you’re at your polling place
The tale of Peter Mui’s broken infrared toaster oven, and how repair can help fix our broken relationship with stuff.
Consumer complaints to the Consumer Financial Protection Bureau (CFPB) regarding vehicle loans and leases have increased sharply during the coronavirus pandemic, according to a new report by OSPIRG and Frontier Group. The analysis suggests that consumers in Oregon and across the United States are facing abusive and deceptive practices from the automobile lending industry.
The maker of Humira, the world’s best-selling drug, faces a new legal challenge over alleged anticompetitive tactics. Monday, the U.S. Public Interest Research Group (U.S. PIRG) filed an amicus brief in the 7th Circuit Court of Appeals arguing that AbbVie’s strategies of reverse payment settlements and creating “patent thickets” have delayed the entry of biologically similar generic drugs (biosimilars) onto the market, costing Americans billions of dollars.
Public Health Campaigns Director Matt Wellington and Dr. Syra Madad detail how people can safely gather this holiday season in the era of COVID-19.
In the midst of the coronavirus outbreak, we’ve taken steps for all of our staff to work remotely for safety reasons. But rest assured, we’ll keep advocating for you as we work for a healthier, safer world.